International expansion of silicone rubber molded products for medical applications and development of new markets
First written in FY2016. 14 of 23 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Silicone rubber molded products exceeded the previous year's level as components for medical devices, including catheters, grew.」
In the medical field, growth in components for medical devices, including catheters, was reported as a factor in performance. - FY2024-Q3RestatedAnnual report
「Silicone rubber molded products saw firm medical-related products, but sluggish general-purpose products left sales struggling to grow.」
Medical-related products remained firm, but sluggish general-purpose products left total sales of silicone rubber molded products struggling to grow. - FY2024-Q2Medical products remained firm, but overall sales were broadly in line with the previous yearAnnual report
「Silicone rubber molded products were sluggish in general-purpose products, but medical-related products remained firm, leaving overall sales at the previous year's level.」
Medical-related products remained firm in connection with the policy of proposing and expanding sales of components for advanced medical devices and pharmaceuticals, while sluggish general-purpose products left total business sales at the previous year's level. - FY2023RaisedAnnual report
「For silicone rubber molded products, we will propose and expand sales of components using extrusion technology for advanced medical devices and pharmaceuticals, which are growth areas.」
The company specified components for advanced medical devices and pharmaceuticals as a new target, moving beyond the previous focus on expanding sales of medical and healthcare products, and identified extrusion technology as the means. - FY2023-Q3AdvancedAnnual report
「For silicone rubber molded products, medical care returned to normal as society learned to live with COVID-19, shipments of core medical products recovered, and overall sales increased substantially.」
Shipments of core medical products recovered as medical care returned to normal, driving substantial growth in sales of silicone rubber molded products. - FY2023-Q1AdvancedAnnual report
「For silicone rubber molded products, shipments of core medical products recovered as the number of patients with infectious diseases declined and the number of routine surgeries increased, driving higher overall sales.」
Shipments of core medical products recovered as routine surgeries increased following a decline in infectious disease patients, driving growth in sales of silicone rubber molded products. - FY2022RestatedAnnual report
「For silicone rubber molded products, we will further expand sales of medical products by leveraging extrusion molding technology while also focusing on developing new products and cultivating new markets.」
The company continues to expand sales of medical products using extrusion molding technology, develop new products and cultivate new markets. - FY2022-Q3RestatedAnnual report
「Shipments of core medical products struggled to grow, and overall sales of silicone rubber molded products were broadly in line with the previous year.」
Shipments of core medical products struggled to grow, and overall sales of silicone rubber molded products remained broadly in line with the previous year. - FY2022-Q1RestatedAnnual report
「Shipments of core medical products struggled to grow, and overall sales of silicone rubber molded products were flat.」
Shipments of core medical products struggled to grow, and overall sales of silicone rubber molded products remained flat. - FY2021-Q2RestatedAnnual report
「Core medical products performed steadily, but overall sales of silicone rubber molded products were flat.」
Core medical products performed steadily, but overall sales of silicone rubber molded products were flat, and the previous conditions continued. - FY2021-Q1Improved from an overall sales decline to performance broadly in line with the previous yearAnnual report
「Core medical products performed steadily, but overall sales of silicone rubber molded products were broadly in line with the previous year.」
Core medical products performed steadily, and overall sales of silicone rubber molded products recovered from the previous fiscal year's decline to broadly match the previous year. - FY2020Medical products remained firm, but overall sales declinedAnnual report
「For silicone rubber molded products, we will further expand sales of medical products by leveraging our proprietary technologies, including high-transparency and composite products, while also focusing on developing new products and cultivating new markets.」
The company has set out further expansion of medical products, new product development and new market development. In the full-year results, medical products performed steadily, but overall sales of silicone rubber molded products declined. - FY2020-Q3RestatedAnnual report
「Core medical products performed steadily, but overall sales of silicone rubber molded products were sluggish.」
Core medical products performed steadily, but overall sales of silicone rubber molded products were sluggish, and the previous business conditions continued. - FY2020-Q2RestatedAnnual report
「Core medical products performed steadily, but overall sales of silicone rubber molded products were sluggish.」
Core medical products performed steadily, but overall sales of silicone rubber molded products were sluggish, and the previous conditions continued. - FY2020-Q1Medical products broadly in line with the previous year, overall sales sluggishAnnual report
「Core medical products performed broadly in line with the previous year, but overall sales of silicone rubber molded products were sluggish.」
Core medical products remained broadly in line with the previous year, while overall sales of silicone rubber molded products were described as sluggish. - FY2019-Q3RestatedAnnual report
「Silicone rubber molded products performed steadily, led by core medical products, and increased sales.」
Core medical products performed steadily and drove higher sales of silicone rubber molded products. No new specific progress in overseas expansion of medical products or new market development was stated. - FY2019-Q2RestatedAnnual report
「Silicone rubber molded products performed steadily, led by core medical products, and increased sales.」
Core medical products performed steadily and drove higher sales, but no new specific progress in overseas expansion of medical products or new market development was stated. - FY2019-Q1RestatedAnnual report
「Silicone rubber molded products performed steadily, led by core medical products, and increased sales.」
Core medical products performed steadily and drove higher sales, but no new specific progress in overseas expansion of medical products or new market development was stated. - FY2018-Q3RestatedAnnual report
「Silicone rubber molded products performed steadily, led by core medical products, but sales did not increase.」
Core medical products performed steadily, but sales did not increase, and the previous business conditions continued. - FY2018-Q2RestatedAnnual report
「Silicone rubber molded products performed steadily, led by core medical products, but sales were broadly in line with the previous year.」
Core medical products performed steadily, but sales were broadly in line with the previous year, with no new progress in overseas expansion or new market development stated. - FY2018-Q1RestatedAnnual report
「Silicone rubber molded products performed steadily, led by core medical products, and sales exceeded the previous year.」
Core medical products performed steadily, and sales of silicone rubber molded products exceeded the previous year. No new progress in overseas expansion or new market development was stated. - FY2017RestatedAnnual report
「For silicone rubber molded products, we will further promote overseas expansion of medical products while focusing on developing new products and cultivating new markets by leveraging our proprietary technologies, including high-transparency and composite products.」
The company continues to pursue overseas expansion of medical products, development of high-transparency and composite products, and cultivation of new markets. - FY2016First statedAnnual report
「For silicone rubber molded products, we will promote overseas expansion of medical products while focusing on developing new products and cultivating new markets by leveraging our proprietary technologies, including high-transparency products.」
The company has indicated overseas expansion of medical products, high-transparency products, new product development and new market development.